½ÃÀ庸°í¼­
»óǰÄÚµå
1747592

È­»ó ¿¬°í ½ÃÀå : Á¦Ç° À¯Çüº°, È­»ó ±íÀ̺°, ÃÖÁ¾ »ç¿ëÀÚº°, Áö¿ªº°

Burn Ointment Market, By Product Type, By Depth of Burn, By End User, By Geography

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Coherent Market Insights | ÆäÀÌÁö Á¤º¸: ¿µ¹® | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

È­»ó ¿¬°í ½ÃÀåÀº 2025³â¿¡´Â 11¾ï 6,060¸¸ ´Þ·¯·Î ÃßÁ¤µÇ°í, 2032³â¿¡´Â 17¾ï 5,670¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, 2025-2032³â CAGR 6.1%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

º¸°í ¹üÀ§ º¸°í¼­ ¼¼ºÎÁ¤º¸
±âÁØ ¿¬µµ 2024³â ½ÃÀå ±Ô¸ð(2025³â) 11¾ï 6,060¸¸ ´Þ·¯
½ÇÀû µ¥ÀÌÅÍ 2020-2024³â ¿¹Ãø ±â°£ 2025-2032³â
¿¹Ãø ±â°£ CAGR(2025-2032³â) : 6.10% °¡Ä¡ ¿¹Ãø(2032³â) 17¾ï 5,670¸¸ ´Þ·¯

È­»óÀº ¿­, È­Çй°Áú, ÇÞºû, ¹æ»ç¼± µî¿¡ ÀÇÇØ ÇǺÎÁ¶Á÷ÀÌ ¼Õ»óÀ» ÀÔ´Â °ÍÀ¸·Î ¹ß»ýÇÕ´Ï´Ù. È­»óÀÇ ´ëºÎºÐÀº »ç°í°¡ ¿øÀÎÀÔ´Ï´Ù. È­»óÀº Á¦1µµ, Á¦2µµ, Á¦3µµ µî ´Ù¾çÇÑ Á¤µµ°¡ ÀÖ½À´Ï´Ù. Á¦1µµ È­»óÀº °æÁõÀÔ´Ï´Ù(´ëºÎºÐÀÇ ¼±Åİú µ¿ÀÏ). ÇǺÎÀÇ ¸Ç À­Ãþ(Ç¥ÇÇ)ÀÌ ºÓ¾îÁö°í ÅëÁõÀ» µ¿¹ÝÇÏÁö¸¸, º¸ÅëÀº ¹°ÁýÀÌ µÇÁö ¾Ê½À´Ï´Ù. Á¦2µµ È­»óÀº ÇǺÎÀÇ ÃÖ»óÃþ°ú ÃÖÇÏÃþ(ÁøÇÇ)ÀÌ Ä§¹üÇÕ´Ï´Ù. µ¿Åë, ¹ßÀû, Á¾Ã¢, ¼öÆ÷ Çü¼ºÀº ¸ðµÎ ÀϾ ¼ö ÀÖ´Â ºÎÀÛ¿ëÀÔ´Ï´Ù. Á¦3µµ È­»óÀº ÇǺÎÀÇ Ç¥ÇÇ, ÁøÇÇ, Áö¹æÀÇ 3Ãþ ¸ðµÎ¿¡ ¿µÇâÀ» ¹ÌĨ´Ï´Ù.

È­»ó ¿¬°í´Â È­»ó ºÎÀ§¿¡ µµÆ÷ÇÏ´Â ±¹¼Ò Åõ¿© Ä¡·áÁ¦·Î Á©, Å©¸², ¿ÀÀÏ, ½ºÇÁ·¹ÀÌ µîÀÇ ÇüÅ·ΠÀÔ¼öÇÒ ¼ö ÀÖ½À´Ï´Ù. È­»ó »óó¸¦ ¹°·Î ½ÄÈù ÈÄ È­»ó ¿¬°í¸¦ µµÆ÷ÇÏ¿© Ä¡·áÇÕ´Ï´Ù. ¿¬°íÀÇ Á¾·ù´Â ¿­»óÀÇ Á¤µµ¿¡ µû¶ó ´Þ¶óÁý´Ï´Ù. ¿¹¸¦ µé¾î, °¡Á¤¾àÀ¸·Î ¾Ë·Î¿¡ º£¶ó Á©À» »ç¿ëÇÏ¿© È­»óÀ» Ä¡·áÇÏ´Â »ç¶÷µµ ÀÖ½À´Ï´Ù. ÇÑÆí, È­»ó Ä¡·á¿¡´Â Ç×»ýÁ¦°¡ µé¾î ÀÖ´Â Å©¸²ÀÌ »ç¿ëµË´Ï´Ù. ÇÏÁö¸¸ Á¦2µµ³ª Á¦3µµ È­»ó Ä¡·á¿¡´Â ¼¼±Õ °¨¿° °¡´É¼ºÀ» ¸·±â À§ÇØ ÇコÄÉ¾î °ø±ÞÀÚ°¡ ¼úÆÄµð¾ÆµòÀº µî ÀºÀ» ÇÔÀ¯ÇÑ ´õ °­·ÂÇÑ Ç×»ýÁ¦ Å©¸²À» ó¹æÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå ¿ªÇÐ

½ÃÀå °³Ã´ÀÚ´Â È­»ó°ú °ü·ÃµÈ ½ÅÁ¦Ç° ¹× ½Å±â¼úÀÇ ½ÂÀÎ ÃëµæÀ» À§ÇÑ ¿¬±¸°³¹ß Ȱµ¿¿¡ ÁÖ·ÂÇϰí ÀÖÀ¸¸ç, À̰ÍÀÌ ¿¹Ãø ±â°£ Áß ¼¼°è È­»ó ¿¬°í ½ÃÀåÀÇ ¼ºÀå¿¡ ±â¿©ÇÒ °¡´É¼ºÀÌ ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¸é, 2020³â 10¿ù, Recce Pharmaceuticals Ltd´Â, °¨¿°µÈ È­»óâÀÇ È¯ÀÚ¸¦ ´ë»óÀ¸·Î ÇÑ ±¤¿ª Ç×»ý ¹°Áú RECCE 327ÀÇ Á¦I/II»ó ÀÓ»ó ½ÃÇèÀ» °³½ÃÇϱâ À§ÇÑ Àΰ£ ¿¬±¸ À±¸® À§¿øÈ¸(HREC)ÀÇ ½ÂÀÎÀ» ÃëµæÇß´Ù°í ¹ßÇ¥Çß½À´Ï´Ù.

½ÃÀå °¢»ç´Â Á¦Ç°ÀÇ Ãâ½Ã¿¡ ÁÖ·ÂÇϰí ÀÖ¾î ¼¼°èÀÇ È­»ó ¿¬°í ½ÃÀå¿¡ À־ ÁöÀ§ °­È­°¡ ±â´ëµË´Ï´Ù. ¿¹¸¦ µé¾î 2020³â 5¿ù 1ÀÏ ½ºÅ²ÄÉ¾î ¾÷°èÀÇ »õ·Î¿î ÇコÅ×Å© Ç÷¹À̾îÀÎ ¸£¸¶¼ÖÀº ±× ù ¹øÂ° Á¦Ç°ÀÎ ¸£¸¶¼ÖÀ» Ãâ½ÃÇß½À´Ï´Ù. ¸£¸¶¼ÖÀº ÇÞºµ¿¡ Ÿ°Å³ª ³ëÈ­ µî ÅÂ¾ç °ü·Ã ÁúȯÀ» ¿¹¹æÇÏ´Â µ¥ µµ¿òÀ» ÁÖ´Â µ¶Æ¯ÇÏ°í ¹ÝÅõ¸íÇÏ°í ¹«ÂüÇÑ Ã³¹æÀÇ ±¤¿ª ½ºÆåÆ®·³ SPF 50 ¹Ì½ºÆ®ÀÔ´Ï´Ù.

½ÃÀå ±â¾÷Àº Àμö ¹× ÆÄÆ®³Ê½Ê°ú °°Àº Àü·«À» äÅÃÇÔÀ¸·Î½á ¼¼°èÀÇ Á¸À縦 È®´ëÇÏ´Â µ¥ °ü¿©Çϰí ÀÖÀ¸¸ç, ÀÌ´Â ¼¼°èÀûÀ¸·Î È­»ó »óó ¿¬°í ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¿¹¸¦ µé¾î 2019³â 5¿ù ¹Ì±¹ ¹ÙÀÌ¿ÀÀǾàǰ ȸ»çÀÎ Vericel CorporationÀº ¿ÏÀü ÅëÇÕÇü ¹ÙÀÌ¿ÀÀǾàǰ ȸ»çÀÎ MediWound Ltd.¿Í µ¿»çÀÇ NexoBrid »ý¹°ÇÐÀû Á¦Á¦¿¡ °üÇÑ ¹Ì±¹¿¡¼­ÀÇ µ¶Á¡Àû ¶óÀ̼¾½º ¹× °ø±Þ °è¾àÀ» ü°áÇß´Ù°í ¹ßÇ¥Çß½À´Ï´Ù.

º» Á¶»çÀÇ ÁÖ¿ä Æ¯Â¡

  • º» º¸°í¼­´Â ¼¼°èÀÇ È­»ó ¿¬°í ½ÃÀåÀ» »ó¼¼ÇÏ°Ô ºÐ¼®Çϰí, 2024³âÀ» ±âÁØ ¿¬µµ·Î ÇÏ¿© 2025-2032³â ¿¹Ãø ±â°£ ½ÃÀå ±Ô¸ð¸¦ Á¦°øÇÕ´Ï´Ù.
  • ¼­·Î ´Ù¸¥ ºÎ¹®¿¡ °ÉÄ£ ÀáÀçÀûÀÎ ¼öÀÍ ±âȸ¸¦ ¹àÇô³»°í ÀÌ ½ÃÀåÀÇ ¸Å·ÂÀûÀÎ ÅõÀÚ Á¦¾È ¸ÅÆ®¸¯½º¸¦ ¼³¸íÇÕ´Ï´Ù.
  • ¶ÇÇÑ ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ, ¾ïÁ¦¿äÀÎ, ±âȸ, ½ÅÁ¦Ç° Ãâ½Ã ¹× ½ÂÀÎ, Áö¿ªº° Àü¸Á, ÁÖ¿ä ±â¾÷ÀÌ Ã¤¿ëÇÏ´Â °æÀï Àü·« µî¿¡ °üÇÑ ÁÖ¿ä ÀλçÀÌÆ®µµ Á¦°øÇÕ´Ï´Ù.
  • ¿£ÅÍÇÁ¶óÀÌÁî °³¿ä, ½ÇÀû, Á¦Ç° Æ÷Æ®Æú¸®¿À, Áö¸®Àû Á¸Àç, À¯Åë Àü·«, ÁÖ¿ä °³¹ß ¹× Àü·«, ¹Ì·¡ °èȹ µîÀÇ ¸Å°³º¯¼ö¸¦ ±â¹ÝÀ¸·Î ¼¼°è »óó ¿¬°í ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷À» ÇÁ·ÎÆÄÀϸµÇÕ´Ï´Ù.
  • ÀÌ º¸°í¼­ÀÇ ÀλçÀÌÆ®¸¦ ÅëÇØ ¸¶ÄÉÆÃ ´ã´çÀÚ ¹× ±â¾÷ °æ¿µÁøÀÌ ÇâÈÄ Á¦Ç° Ãâ½Ã, ±â¼ú Çâ»ó, ½ÃÀå È®´ë, ¸¶ÄÉÆÃ Àü¼ú¿¡ ´ëÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç °áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù.
  • ¼¼°èÀÇ »óó ¿¬°í ½ÃÀå º¸°í¼­´Â ÅõÀÚÀÚ, °ø±Þ¾÷ü, Á¦Á¶¾÷ü, À¯Åë¾÷ü, ½Å±Ô Âü°¡ÀÚ, À繫 ºÐ¼®°¡ µî ÀÌ ¾÷°èÀÇ ´Ù¾çÇÑ ÀÌÇØ°ü°èÀÚ¸¦ Áö¿øÇÕ´Ï´Ù.
  • ÀÌÇØ°ü°èÀÚ´Â ¼¼°èÀÇ È­»ó ¿¬°í ½ÃÀå ºÐ¼®¿¡ »ç¿ëµÇ´Â ´Ù¾çÇÑ Àü·« ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ÀÇ»ç °áÁ¤À» ¿ëÀÌÇÏ°Ô ÇÒ ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¸ñÀû ¹× ÀüÁ¦Á¶°Ç

  • Á¶»ç ¸ñÀû
  • ÀüÁ¦Á¶°Ç
  • ¾à¾î

Á¦2Àå ½ÃÀå Àü¸Á

  • º¸°í¼­ ¼³¸í
    • ½ÃÀå Á¤ÀÇ ¹× ¹üÀ§
  • ÁÖ¿ä ¿ä¾à
  • ÀϰüµÈ ±âȸ Áöµµ(COM)

Á¦3Àå ½ÃÀå ¿ªÇÐ, ±ÔÁ¦ ¹× µ¿Ç⠺м®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ½ÃÀå ±âȸ
  • ÃÖ±Ù µ¿Çâ
  • ÇÕº´, Àμö ¹× Á¦ÈÞ
  • ±ÔÁ¦ ½Ã³ª¸®¿À
  • ÁÖ¿ä ¹ßÀü
  • PEST ºÐ¼®
  • Porter's Five Forces ºÐ¼®

Á¦4Àå ¼¼°èÀÇ È­»ó ¿¬°í ½ÃÀå : Á¦Ç° À¯Çüº°(2020-2032³â)

  • ±¹¼Ò Ç×»ýÁ¦
  • Àº
  • ¿ä¿Àµå

Á¦5Àå ¼¼°èÀÇ È­»ó ¿¬°í ½ÃÀå : È­»ó ±íÀ̺°(2020-2032³â)

  • ¾èÀº È­»ó
  • ºÎºÐÃþ È­»ó
  • ÀüÃþ È­»ó

Á¦6Àå ¼¼°èÀÇ È­»ó ¿¬°í ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°(2020-2032³â)

  • º´¿ø
  • Àü¹® Ŭ¸®´Ð
  • ±âŸ

Á¦7Àå ¼¼°èÀÇ È­»ó ¿¬°í ½ÃÀå : Áö¿ªº°(2020-2032³â)

  • ºÏ¹Ì
      • ¹Ì±¹
      • ij³ª´Ù
  • ¶óƾ¾Æ¸Þ¸®Ä«
      • ºê¶óÁú
      • ¸ß½ÃÄÚ
      • ¾Æ¸£ÇîÆ¼³ª
      • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
  • À¯·´
      • ¿µ±¹
      • µ¶ÀÏ
      • ÀÌÅ»¸®¾Æ
      • ÇÁ¶û½º
      • ½ºÆäÀÎ
      • ·¯½Ã¾Æ
      • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
      • Áß±¹
      • Àεµ
      • ÀϺ»
      • ASEAN
      • È£ÁÖ
      • Çѱ¹
      • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • Áßµ¿
      • GCC
      • À̽º¶ó¿¤
      • ±âŸ Áßµ¿
  • ¾ÆÇÁ¸®Ä«
      • ºÏ¾ÆÇÁ¸®Ä«
      • Áß¾Ó ¾ÆÇÁ¸®Ä«
      • ³²¾ÆÇÁ¸®Ä«

Á¦8Àå °æÀï ±¸µµ

  • ±â¾÷ ÇÁ·ÎÆÄÀÏ
    • Smith &Nephew PLC
    • Wisconsin Pharmacal Company
    • Johnson &Johnson
    • Pfizer Inc.
    • Cipla Ltd.
    • Mankind Pharma Ltd.
    • Dr. Morepen Ltd.
    • GlaxoSmithKline PLC.
    • MediWound
    • Analysts'Views

Á¦9Àå ¼½¼Ç

  • Âü°í¹®Çå
  • Á¶»ç ¹æ¹ý
AJY 25.06.23

Burn Ointment Market is estimated to be valued at USD 1,160.6 Mn in 2025 and is expected to reach USD 1,756.7 Mn in 2032, exhibiting a compound annual growth rate (CAGR) of 6.1% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 1,160.6 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 6.10% 2032 Value Projection: USD 1,756.7 Mn

A burn occurs when skin tissue is damaged by heat, chemicals, sunlight, electricity, or radiation. The majority of burns are caused due to accidents. There are various degrees of burns- first degree, second degree and third degree burns. First-degree burns are minor (like most sunburns). The top layer of skin (epidermis) turns red and painful, but it usually does not blister. Second-degree burns affect the top and bottom layers of the skin (dermis). Pain, redness, swelling, and blistering are all possible side effects. Third-degree burns affect all three layers of the skin: the epidermis, dermis, and fat.

Burn ointment is a topically administered treatment applied on the burnt area of our body and is available in the form of gels, creams, oils and sprays. After cooling the burn injury with water, burn ointments are applied to heal the burn wounds. The types of ointment used depends upon the severity of burns. For example, some people use aloe vera gel as a home remedy to treat sunburns. While antibiotic creams are used to treat thermal burns. However, for the treatment of second and third degree burns, the healthcare provider may prescribe a stronger antibiotic cream containing silver, such as silver sulfadiazine, to prevent possible bacterial infections.

Market Dynamics

Market players are focused on research and development activities to obtain approvals for new products or techniques associated with burn injuries, which could contribute to the growth of the global burn ointment market over the forecast period. For instance, in Oct 2020, Recce Pharmaceuticals Ltd announced that it has received Human Research Ethics Committee (HREC) approval to begin a Phase I/II clinical trial of its broad-spectrum antibiotic RECCE 327 on patients with infected burn wounds.

Market players are focusing on product launches, which is expected to strengthen their position in the global burn ointment market. For instance, on May 1, 2020, LUMASOL, a new health tech player in the skincare industry, launched its first product lumasol, a broad-spectrum SPF 50 mist with a unique, translucent, and cruelty-free formula that helps prevent sun-related disease such as sunburns and ageing.

Market players are involved in expanding their global presence by adopting strategies such as acquisitions and partnerships, this is expected to drive the growth of the global burn ointment market globally. For instance, in May 2019, Vericel Corp., an American biopharmaceutical company announced an exclusive U.S. licensing and supply agreement with MediWound Ltd., a fully-integrated biopharmaceutical company for its NexoBrid biological product.

Key features of the study:

  • This report provides an in-depth analysis of global burn ointment market, provides market size (US$ Million), and compound annual growth rate (CAGR %) for the forecast period 2025-2032, considering 2024 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
  • It profiles leading players in the global burn ointment market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
  • Key companies covered as a part of this study include Smith & Nephew PLC, Wisconsin Pharmacal Company, Johnson & Johnson, Pfizer Inc., Cipla Ltd., Mankind Pharma Ltd., Dr. Morepen Ltd., and GlaxoSmithKline PLC.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
  • The global burn ointment market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision making through various strategy matrices used in analyzing the global burn ointment market.

Market Segmentation

  • Global Burn Ointment Market, By Product Type
    • Topical Antibiotics
    • Silver
    • Iodine
  • Global Burn Ointment Market, By Depth of Burn
    • Minor Burns
    • Partial Thickness Burns
    • Full Thickness Burns
  • Global Burn Ointment Market, By End User
    • Hospitals
    • Specialty Clinics
    • Others
  • Global Burn Ointment Market, By Region
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Company Profiles
    • Smith & Nephew PLC
    • Wisconsin Pharmacal Company
    • Johnson & Johnson
    • Pfizer Inc.
    • Cipla Ltd.
    • Mankind Pharma Ltd.
    • Morepen Ltd.
    • GlaxoSmithKline PLC

Table of Contents

1. Research Objective and Assumption

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Product Type
    • Market Snippet, By Depth of Burn
    • Market Snippet, By End User
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Recent Trends
  • Mergers, Acquisitions, and Collaborations
  • Regulatory Scenario
  • Key Developments
  • PEST Analysis
  • Porter's Analysis

4. Global Burn Ointment Market, By Product Type, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021-2032
    • Segment Trends
  • Topical Antibiotics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
    • Segment Trends
  • Silver
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
    • Segment Trends
  • Iodine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
    • Segment Trends

5. Global Burn Ointment Market, By Depth of Burn, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021-2032
    • Segment Trends
  • Minor Burns
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
    • Segment Trends
  • Partial Thickness Burns
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
    • Segment Trends
  • Full Thickness Burns
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
    • Segment Trends

6. Global Burn Ointment Market, By End User, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021-2032
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
  • Specialty Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)

7. Global Burn Ointment Market, By Region, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021-2032
    • Segment Trends
  • North America
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Depth of Burn, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Mn)
      • U.S.
      • Canada
  • Latin America
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Depth of Burn, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Mn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Depth of Burn, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Mn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Depth of Burn, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Mn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Depth of Burn, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Mn)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Depth of Burn, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032, (US$ Mn)
      • North Africa
      • Central Africa
      • South Africa

8. Competitive Landscape

  • Company Profiles
    • Smith & Nephew PLC
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Wisconsin Pharmacal Company
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Johnson & Johnson
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Pfizer Inc.
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Cipla Ltd.
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Mankind Pharma Ltd.
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Dr. Morepen Ltd.
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • GlaxoSmithKline PLC.
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • MediWound
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Analysts' Views

9. Section

  • References
  • Research Methodology
  • About us and Sales Contact
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦